.jpg "Leveraging Innovation to Achieve Self-reliance in Pharmaceuticals")
Indian pharmaceutical companies are planning to increase their research spending in the next five years duration. The Indian pharmaceutical market is projected to grow and reach $130 bn in the next ten years.
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure, and cancer, has announced a significant expansion of its intellectual property portfolio for its DSR (Direct Sodium Removal) programme. A key...
The FDA has approved the expanded use of Regeneron Pharmaceuticals Inc's drug in children aged 5 to 11 years to treat an ultra-rare disease that causes high cholesterol levels. Evkeeza was approved in February 2021 as a supplement to other...
Orbis established the Green Vision Center (GVC) in Satara, Maharashtra, in collaboration with the PBMA's H V Desai Eye Hospital. The center's mission is to provide primary eye care and quality optical services to the communities in an...
A person in the know informed sources that Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure, has filed data for its mRNA-based Omicron specific Covid-19 booster shot for approval to the drug regulator, despite an increase...
Sukino Healthcare Solutions, India's first comprehensive continuum of care provider for long-term healthcare management, has received a Rs. 50 crore Series-A private equity investment from Stakeboat Capital...
The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and push down prices for a medication used by millions of....
In today's world, product safety has become a key priority for the pharmaceutical industry. As such, the use of smart packaging and related technologies has become increasingly important.
OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease (DED) in order to address the significant unmet need in this multibillion-dollar market, announced that its planned trial...
Eris Lifesciences Limited has revealed the purchase of nine dermatology brands from Dr Reddy's Laboratories for a total of Rs 2,750 million. The majority of the products are in cosmetology categories such as anti-acne, moisturisers, cleansers,...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")